A Study to Learn About the Safety of BIIB115 Injections and How BIIB115 is Processed in the Bodies of Healthy Adult Male Volunteers and of Pediatric Participants With Spinal Muscular Atrophy Who Previously Took Onasemnogene Abeparvovec
Clinical trial NCT05575011 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05575011
- Sponsor
- Biogen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-10
- Primary completion
- 2031-11-14
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.